Camber Capital Management LP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Quarter-by-quarter ownership
Camber Capital Management LP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$5,514,000
-90.5%
100,000
-86.3%
0.14%
-95.1%
Q4 2019$58,028,000
-39.1%
730,000
-59.4%
2.95%
-37.8%
Q1 2019$95,274,000
+3.2%
1,800,000
-20.0%
4.75%
+8.3%
Q4 2018$92,363,000
+17.1%
2,250,000
+8.4%
4.38%
+29.9%
Q3 2018$78,850,000
-20.7%
2,075,000
-5.7%
3.37%
-11.8%
Q2 2018$99,440,000
+71.6%
2,200,000
+83.3%
3.83%
+34.4%
Q1 2018$57,960,000
+84.1%
1,200,000
+50.0%
2.85%
+84.7%
Q4 2017$31,480,000800,0001.54%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders